Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
2021 ◽
Vol 27
(3)
◽
pp. S136-S137
2018 ◽
Vol 24
(4)
◽
pp. 751-757
◽
2018 ◽
Vol 93
(6)
◽
pp. 769-777
◽